Portal de Periódicos da CAPES

RoBo-1, a Novel Member of the Urokinase Plasminogen Activator Receptor/CD59/Ly-6/Snake Toxin Family Selectively Expressed in Rat Bone and Growth Plate Cartilage

1998; Elsevier BV; Volume: 273; Issue: 7 Linguagem: Inglês

10.1074/jbc.273.7.3878

1083-351X

L. Staton Noel, Brian Champion, Christopher L. Holley, Caroline J. Simmons, David C. Morris, J. Alan Payne, Jenny M. Lean, Timothy Chambers, Gul Zaman, Lance E. Lanyon, Larry J. Suva, Larry R. Miller,

Blood properties and coagulation

Using differential display polymerase chain reaction, we cloned a novel cDNA named RoBo-1 from rat tibia. RoBo-1 is abundantly expressed in bone, including the hypertrophic chondrocytes of the growth plate where cartilage is remodeled into bone. RoBo-1 mRNA expression increased in response to two modulators of bone metabolism, estradiol and intermittent mechanical loading, suggesting a role in bone homeostasis. The 1.6-kilobase cDNA encodes a 240-amino acid protein with a cysteine spacing pattern, suggesting that RoBo-1 is a novel member of the urokinase plasminogen activator receptor/CD59/Ly-6/snake toxin family. Furthermore, the C-terminal contains a glycosyl-phosphatidylinositol attachment site, suggesting that it is a cell surface protein similar to other mammalian members of this family. The strongest homology of RoBo-1 is to the snake serum-derived phospholipase A2 inhibitors, which uniquely contain two of the cysteine domains but are secreted proteins. Interestingly, RoBo-1 is likely the first membrane-anchored member of this family containing two cysteine domains. Thus, the tissue specificity, responsiveness to bone protective mediators, along with its relationship to the multifunctional urokinase plasminogen activator receptor/CD59/Ly-6/snake toxin family suggests that RoBo-1 may play a novel role in the growth or remodeling of bone. Using differential display polymerase chain reaction, we cloned a novel cDNA named RoBo-1 from rat tibia. RoBo-1 is abundantly expressed in bone, including the hypertrophic chondrocytes of the growth plate where cartilage is remodeled into bone. RoBo-1 mRNA expression increased in response to two modulators of bone metabolism, estradiol and intermittent mechanical loading, suggesting a role in bone homeostasis. The 1.6-kilobase cDNA encodes a 240-amino acid protein with a cysteine spacing pattern, suggesting that RoBo-1 is a novel member of the urokinase plasminogen activator receptor/CD59/Ly-6/snake toxin family. Furthermore, the C-terminal contains a glycosyl-phosphatidylinositol attachment site, suggesting that it is a cell surface protein similar to other mammalian members of this family. The strongest homology of RoBo-1 is to the snake serum-derived phospholipase A2 inhibitors, which uniquely contain two of the cysteine domains but are secreted proteins. Interestingly, RoBo-1 is likely the first membrane-anchored member of this family containing two cysteine domains. Thus, the tissue specificity, responsiveness to bone protective mediators, along with its relationship to the multifunctional urokinase plasminogen activator receptor/CD59/Ly-6/snake toxin family suggests that RoBo-1 may play a novel role in the growth or remodeling of bone. To reduce the risk of fracture, the skeleton responds to local mechanical forces by forming new bone at these highly stressed sites (1Lanyon L.E. J. Bone Miner. Res. 1992; 7: 369-375Crossref PubMed Scopus (300) Google Scholar). Maintenance of bone tissue is a unique process that probably requires specialized proteins. Identification of the bone-specific proteins involved in this process could enhance our understanding and ability to treat bone diseases such as osteoporosis. Despite years of intensive study, very few proteins have been identified that are expressed primarily in bone tissue. The development of molecular biology techniques based on differential expression of mRNA provides new opportunities to identify novel bone-specific proteins such as the recently described osteoclast protease cathepsin K (2Tezuka K. Tezuka Y. Meejima A. Sato T. Nemoto K. Kamioka H. Hakeda Y. Kumegawa M. J. Biol. Chem. 1994; 269: 1106-1109Abstract Full Text PDF PubMed Google Scholar). Using differential display polymerase chain reaction (DD-PCR) 1The abbreviations used are: DD-PCR, differential display polymerase chain reaction; PLA2, phospholipase A2; bp, base pair(s); uPAR, urokinase plasminogen activator receptor; m7G(5′)ppp(5′)G, P 1-5′-(methylguanosine)-P3-5′-GTP. (3Liang P. Pardee A.B. Science. 1992; 257: 967-971Crossref PubMed Scopus (4707) Google Scholar), we sought to identify new bone-specific proteins directly from whole bone tissue. We report here the discovery of a novel cDNA named RoBo-1 (Rodent Bone) that is expressed abundantly in bone, including the lengthening growth plate where cartilage is remodeled into bone, but is not significantly expressed in any other tissues examined. Bone strength is regulated by a coupled process of formation and resorption. These processes are regulated by both systemic hormones and local factors. For instance, after menopause or ovariectomy there is rapid loss of bone due to a relative increase of resorption relative to bone formation (4Canalis E. Regulation of Bone Remodeling. Lippincott-Raven Publishers, Philadelphia1996: 29-34Google Scholar). Administration of estrogen can prevent this loss of bone by restoring the balance of formation and resorption. However, mechanical forces are the predominant signal that determine the local architecture needed to provide optimum strength (5Frost H.M. Calcif. Tissue. Int. 1988; 42: 145-156Crossref PubMed Scopus (324) Google Scholar). The critical need for mechanical load is most obviously seen during immobilization and space flight where bone is lost rapidly despite normal hormone levels (6Bikle D.D. Harris J. Halloran B.P. Morey-Holton E. Am. J. Physiol. 1994; 30: E822-E827Google Scholar). Conversely, the application of repetitive forces to bone results in additional bone tissue being added to the mechanically stressed site to maintain the structural integrity of the bone (7Chow J.W.M. Jagger C.J. Chambers T.J. Am. J. Physiol. 1993; 265: E340-E347Crossref PubMed Google Scholar, 8Torrance A.G. Mosley J.R. Suswillo R.F.L. Lanyon L.E. Calcif. Tissue. Int. 1994; 54: 241-247Crossref PubMed Scopus (244) Google Scholar). Interestingly, we have observed that RoBo-1 mRNA levels increased after both estrogen treatment and with repetitive mechanical loading regimes in rats. RoBo-1 is a new member of the emerging multifunctional uPAR/CD59/Ly-6/snake toxin family (9Ploug M. Ellis V. FEBS Lett. 1994; 349: 163-168Crossref PubMed Scopus (243) Google Scholar). Despite a diverse array of functions, the family is characterized by a motif of 8–10 similarly spaced cysteines forming a common three-dimensional structure (9Ploug M. Ellis V. FEBS Lett. 1994; 349: 163-168Crossref PubMed Scopus (243) Google Scholar). Most of the members contain a single motif, except for uPAR, which contains three internal motifs, and the recently described snake serum-derived phospholipase A2 (PLA2) inhibitors, which contain two motifs (10Fortes-Dias C.L. Lin Y. Ewell J. Diniz C.R. Liu T.-Y. J. Biol. Chem. 1994; 269: 15646-15651Abstract Full Text PDF PubMed Google Scholar, 11Ohkura N. Inoue S. Ikeda K. Hayashi K. Biochem. Biophys. Res. Commun. 1994; 200: 784-788Crossref PubMed Scopus (34) Google Scholar). The relationship of RoBo-1 to this family of proteins as well as its cellular localization and regulation suggests a novel role in bone metabolism. RNA for PCR experiments was purified from tissues from 4-month-old female CD rats (Charles River Laboratories, Wilmington, MA) using an RNA isolation kit from Stratagene (La Jolla, CA). 2Glaxo Wellcome meets or exceeds animal care and use regulations set forth in the Animal Welfare Act and its implementing regulations and is accredited by American Association of Laboratory Animal Care. Briefly, frozen tissues were pulverized under liquid nitrogen using a mortar and pestle and transferred to a 50-ml polypropylene tube. Immediately after the nitrogen evaporated, 10 ml of guanidinium thiocyanate solution containing 1 μl of antifoam A (Sigma) were added, and the tissues were homogenized with a Polytron (Brinkman Littau, Switzerland) at high speed. Homogenates were transferred to 15-ml Corex tubes and centrifuged at 10,000 × g for 15 min to remove particulates. The supernatant was removed and transferred to a 50-ml tube. RNA was isolated according to manufacturer's directions. mRNA was isolated from total RNA using oligo(dT) spin column kit from Pharmacia Biotech Inc. The mRNA was double-selected according to the protocol. Total RNA from tibia, kidney, spleen, and brain was treated with RNase-free DNase using the Message Clean Kit from GenHunter Corp. (Brookline, MA) before DD-PCR. For DD-PCR, RNA from whole tibia, which included the periosteum, marrow, and epiphyses, was used. PCR was performed according to the GenHunter kit with the following modifications. Three separate reverse transcription reactions containing 0.2 μg of RNA was performed for each 3′ primer. These reactions were pooled to reduce variability in this step. For each arbitrary primer, duplicate PCR reactions were performed using 2 μl of the pooled reverse transcriptase reaction/20-μl reaction. Samples were thermocycled 40 times as follows: 30 s at 94 °C, 2 min at 40 °C, 30 s at 72 °C followed by a final extension at 72 °C for 5 min. 10 μl of the PCR products were diluted with 1 μl of 10 × gel loading buffer and analyzed on a 6% nondenaturing Tris-borate-EDTA gel. Gels were dried and exposed to x-ray film (X-Omat, Eastman Kodak Co.) overnight. Reproducible bands were excised, extracted, and reamplified according to instructions. Reamplified PCR fragments were subcloned into pGEM-T vector (Promega Madison, WI). Plasmid DNA was prepared using the Qiagen (Chatsworth, CA) miniprep kit. Amplitaq dideoxy sequencing was performed on a Applied Biosystems (Foster City, CA) ABI373A automated sequencer. Three independent full-length clones and one truncated clone were sequenced bidirectionally. Sequences were analyzed by Sequencher software (Gene Codes Corp.), and data bases searches were performed by both BLAST and FASTA algorithms. Multiple rat tissue Northern blots were purchased from CLONTECH (Palo Alto, CA). For blots containing bone mRNA, 2 μg of double-selected mRNA made from total RNA prepared as described above was blotted to Hybond N (Amersham Life Science, Inc.) in 10 × SSC (1 × SSC = 0.15m sodium chloride, 0.015 m sodium citrate, pH 7.0) and cross-linked with a Stratalinker (Stratagene) set on auto-cross-link. For Northern blots containing total RNA, the amount loaded is indicated in the figure legend. Primary osteoblasts were prepared and cultured as described previously (12Zaman G. Suswillo R.F.L. Cheng M.Z. Tavares I.A. Lanyon L.E. J. Bone Miner. Res. 1997; 12: 769-777Crossref PubMed Scopus (86) Google Scholar) and RNA prepared as described above. Prehybridization and hybridization was done in 6 × SSC, 10% dextran sulfate, 1% SDS, 200 μg/ml salmon sperm DNA at 42 °C. Probes were labeled with [32P]dCTP (Amersham) using a random priming kit (Life Technologies, Inc.) and purified using NucTrap columns (Stratagene). Approximately 1 × 106 cpm/ml were added. Final wash of blots was done in 0.1 × SSC, 0.1% SDS at 55 °C. A custom made rat tibia Lambda Zap II cDNA library (Stratagene) was screened with the [32P]dCTP-labeled PCR product according to the manufacturer's directions. Multiple primary plaques were selected and rescreened until clonal. Clonal plaques were excised using the EXASSIST/SOLR system (Stratagene). Plasmid DNA was prepared using a Qiagen plasmid kit. RoBo-1 cDNA (nucleotides 69–886) was transcribed and capped (m7G(5′)ppp(5′)G) according to the directions in Ambion's (Austin, TX) mMessage mMachine kit. RoBo-1 (0.3 μg/25 μl reaction) was translated with rabbit reticulocyte lysates (Promega) in the absence or presence of 1.5 μl of canine microsomal membranes (Promega). 1.5 μl was analyzed on a 12% SDS-polyacrylamide gel. For determination of N-glycosylation, 5 μl of the translational products were diluted in denaturing buffer (Oxford Glycosystems, Rosedale, NY), heated at 55 °C for 5 min, and treated for 18 h at 37 °C in the absence or presence of peptide-N-glycosidase F (Oxford Glycosystems). One-fourth of the reaction was analyzed on a 12% SDS-polyacrylamide gel. In the rat tail vertebral compression model, pins were inserted into the seventh and ninth caudal vertebrae on 13-week-old female Wistar rats as described previously (7Chow J.W.M. Jagger C.J. Chambers T.J. Am. J. Physiol. 1993; 265: E340-E347Crossref PubMed Google Scholar), and the eighth caudal vertebrae were subjected to a single 5-min episode of axial loading using 300 cycle (1 Hz) to produce a peak strain magnitude of 700 microstrain over the cortex. These procedures were performed under general anesthesia (2% halothane in 2 liter/min of 02 and 1 liter/min of N2O). A control group was pinned but not subjected to the loading regime. Animals were sacrificed 1, 6, and 24 h after loading after intracardiac perfusion-fixation with 4% paraformaldehyde for 15 min, general anesthesia using 60 mg/kg pentobarbital sodium. Sixth and eighth caudal vertebrae were postfixed in 4% paraformaldehyde at 4 °C for a further 24 h, decalcified in 10% EDTA in phosphate-buffered saline and embedded in paraffin wax. The nonsurgical axial loading system was used to load 16 100-g female Sprague-Dawley rats as described previously (8Torrance A.G. Mosley J.R. Suswillo R.F.L. Lanyon L.E. Calcif. Tissue. Int. 1994; 54: 241-247Crossref PubMed Scopus (244) Google Scholar). In each case the left ulna was loaded, and the right ulna served as a control. The animals were placed in dorsal recumbency with the left antebrachium being held between two padded cups, one in contact with the olecranon process of the ulna, the other in contact with the flexed carpus. The loading protocol used a 1.5-Hz ramped square wave generated by Snapmaster for Windows (HEM Data Corporation, Southfield, MI) run into an Instron servohydraulic material testing machine. The animals were loaded for 10 min (1,200 cycles, 2 Hz) with the peak load set at 12 newton. After loading, the animals were allowed to recover and were sacrificed 6 h later. The left and right ulna were removed by careful dissection; with the removal of all muscle, the periosteum was left intact. The diaphysial region was removed, and the marrow cavity was flushed with phosphate-buffered saline. The bones were frozen in liquid nitrogen for RNA isolation. For estrogen experiments, female Sprague-Dawley rats, ovariectomized 4 weeks before (at ∼150 grams), received a single oral dose of estradiol (30 μg/kg). Control rats received vehicle control (10% EtOH, phosphate-buffered saline). Whole metaphyses from tibia were harvested for RNA isolation 24 and 48 h after administration of estrogen (13Suva L.J. Seedor J.G. Endo N. Quartuccio H.A. Thompson D.D. Bab I. Rodan G.A. J. Bone Miner. Res. 1993; 8: 379-388Crossref PubMed Scopus (134) Google Scholar). RoBo-1 cDNA (nucleotides 69–886) was subcloned into the XbaI site of pBluescript II KS(−) (Stratagene). The vector was linearized with NotI and transcribed with T3 polymerase in the presence of 35S-UTP to generate the antisense probe. The sense strand was generated by linearizing with HindIII and transcribing with T7 polymerase. Mid-coronal sections of the vertebrae 6 μmthick were cut and mounted onto glass slides coated with 3-aminopropyltriethoxysilane (Sigma). Prehybridization was performed as described previously (14Lean J.M. Jagger C.J. Chambers T.J. Chow J.W.M. Am. J. Physiol. 1995; 268: E318-E327PubMed Google Scholar). Sections were hybridized against radiolabeled probe (5 × 104 cpm/μl) for 16 h at 45 °C in a humidified environment. Sections were rinsed 2 times with 2 × SSC at room temperature and incubated with ribonuclease A (50 μg/ml, Sigma) for 30 min in 2 × SSC at 37 °C. Sections were submitted to two more 1 × SSC washes at room temperature before final wash in 0.5 × SSC at 50 °C. The sections were dehydrated in graded alcohols containing 0.3 m ammonium acetate and air-dried. For autoradiography, sections were coated with nuclear emulsion K5 (Ilford, UK). After a two week exposure, slides were developed, counterstained with hematoxylin and eosin, and mounted. To identify mRNAs expressed exclusively in rat bone, we compared DD-PCR patterns from whole tibia to those of kidney, spleen, and brain. These tissues allowed us to eliminate potential common mRNAs from calcium-responsive, hematopoietic, and neuronal tissues respectively. Using a limited number of primer sets, we isolated 23 DD-PCR bands that were only visible in the lanes containing bone RNA. After subcloning, sequencing, and Northern blot analysis, only two were novel, bone-specific cDNAs. One of these novel cDNAs, which we named RoBo-1, hybridized to a 1.6-kilobase mRNA that was expressed abundantly in bone yet showed little or no expression in other tissues (Fig. 1 A, top blot). Using the cloned PCR product as a probe, we isolated three identical 1,607-bp full-length cDNA clones from a rat tibia cDNA library. Northern blot analysis of rat tissues using this full-length cDNA probe confirmed the tissue distribution of RoBo-1 (Fig. 1 A, middle blot). We also found RoBo-1 to be expressed in calvarial bone, caudal vertebrae, tibial marrow, and diaphysial bone denuded of marrow and periosteum (Fig. 1 B). Furthermore, RoBo-1 was expressed in primary rat osteoblast cells isolated by sequential collagenase digestion (Fig. 1 B) (12Zaman G. Suswillo R.F.L. Cheng M.Z. Tavares I.A. Lanyon L.E. J. Bone Miner. Res. 1997; 12: 769-777Crossref PubMed Scopus (86) Google Scholar). Surprisingly, Northern blot (Fig. 1 B) and PCR analysis (not shown) did not show expression of RoBo-1 in the osteoblast-like cell lines ROS 17/2.8 and UMR106. In addition, no expression was observed in the fibroblastic (Rat 1), the prostatic (MLL), nor the chondrocytic (IRC) cell lines (Fig. 1 B) (15Horton W.E. Cleveland J. Rapp U. Nemuth G. Bolander M. Doege K. Yamada Y. Hassell J.R. Exp. Cell Res. 1988; 178: 457-468Crossref PubMed Scopus (70) Google Scholar). These data suggested that the bone-specific expression of RoBo-1 is further restricted to specific cell types or differentiation stages. The RoBo-1 cDNA contains a 110-bp 5′-untranslated region, an open reading frame of 720 bp coding for 240 amino acids (Fig.2), and 777 bp of 3′-untranslated bases. This 3′-untranslated region sequence contained one potential polyadenylation signal and a rodent B2 repetitive element (16Hendriks W. Bloemendal H. de Jong W.W. Nucleic Acids Res. 1987; 15: 9093Crossref PubMed Scopus (2) Google Scholar). After removal of this repetitive element, we searched the DNA data bases and found no significant homology of the RoBo-1 cDNA to known sequences. Searching for protein homologies using the BLASTP algorithm revealed a significant homology of RoBo-1 to the 25 kDa (24% identity) and 30 kDa (26% identity) chains of the PLA2 inhibitor from monocled cobra Naja naja kauothia (Fig. 2) (17Ohkura N. Inoue S. Ikeda K. Hayashi K. Biochem. Biophys. Res. Commun. 1994; 204: 1212-1218Crossref PubMed Scopus (56) Google Scholar). Using the FASTA algorithm, the strongest homology was found to be to a related PLA2 inhibitor protein, the Crotalus neutralizing factor (27.7% identity) from the South American rattlesnake Crotalus durissus terrificus (10Fortes-Dias C.L. Lin Y. Ewell J. Diniz C.R. Liu T.-Y. J. Biol. Chem. 1994; 269: 15646-15651Abstract Full Text PDF PubMed Google Scholar). Similarity of RoBo-1 to these proteins was estimated to be approximately 45–47% (18Needleman S.B. Wunsch C.D. J. Mol. Biol. 1970; 48: 443-453Crossref PubMed Scopus (7866) Google Scholar). Results of data base searching also revealed homology of RoBo-1 to the urokinase plasminogen activator receptor (uPAR). This correlation was significant since the snake PLA2 inhibitors and uPAR belong to a structurally related family of proteins that include uPAR, CD59, Ly-6, and snake venom neurotoxins (9Ploug M. Ellis V. FEBS Lett. 1994; 349: 163-168Crossref PubMed Scopus (243) Google Scholar). Although these proteins have diverse functions, the family is characterized by a common cysteine-rich domain of 70–90 amino acids containing 8–10 regularly spaced cysteines capable of forming disulfide bonds (Fig.3) (19Ploug M. Kjalke M. Ronne E. Weidle U. Hoyer-Hansen G. Dano K. J. Biol. Chem. 1993; 268: 17539-17546Abstract Full Text PDF PubMed Google Scholar). All of the mammalian members of this family contain a single 90-amino acids cysteine-rich domain with the exception of uPAR, which has three sequential domains. Based on the cysteine spacing, RoBo-1 likely has two of these cysteine-rich domains similar to the snake PLA2 inhibitors, to which it has the closest homology. The first such domain (amino acids 29–108) contains 10 cysteine residues as well as the conserved family motif CCXXXXCN, whereas the second domain (amino acids 127–195) has 8 cysteines, similar to the snake toxins. RoBo-1 is the first mammalian protein identified to have two sequential uPAR/CD59/Ly-6-like domains. The computer program PSORT (Prediction of Protein Localization Sites) (20Nakai K. Kaneshisa M. Genomics. 1992; 14: 897-911Crossref PubMed Scopus (1368) Google Scholar) suggested that the 21 hydrophobic residues at the N terminus could function as a signal sequence indicative of a secreted or membrane-associated protein. PSORT also predicted that RoBo-1 could be a type 1 membrane protein containing a short, hydrophobic trans-membrane domain made up of residues 218–234, which would leave a cytoplasmic tail of only six amino acids. However, as an alternative to membrane insertion, PSORT revealed the presence of a glycosylphosphatidylinositol linkage site, which suggested a potential covalent attachment to phosphatidylinositol on the cell membrane similar to other mammalian uPAR/CD59/Ly-6 proteins. We verified that the RoBo-1 cDNA could serve as a template for protein synthesis using in vitro translation in both rabbit reticulocyte (Fig. 4) and wheat germ extracts (not shown). These experiments revealed a predominant protein of 25–30 kDa, consistent with the predicted open reading frame of 26.2 kDa (Fig. 4, lane 1). The protein sequence contains four possible N-linked glycosylation sites. Co-translation in the presence of canine microsomal membranes resulted in post-translation modifications that increased the molecular mass to 37–40 kDa (Fig. 4, lane 2). Treatment of extracts containing this modified RoBo-1 with peptide-N-glycosidase F (21Plummer T.H. Tarentino A.L. Glycobiology. 1991; 1: 257-263Crossref PubMed Scopus (141) Google Scholar) reduced the molecular mass of the translated product to the original size (Fig. 4, lanes 3–5), which verified that RoBo-1 has at least one functional N-linked glycosylation site. To further localize the expression of RoBo-1 within bone, we performedin situ hybridization on longitudinal sections of rat caudal vertebrae. RoBo-1 cDNA showed labeling of the epiphyseal chondrocytes, where cartilage is resorbed and replaced by bone, as well as cells in the primary spongiosa (see Fig.5, panels A (low magnification) and B (higher magnification)). This area is responsible for bone growth, and impairment of its function is associated with reduced bone volume (22Amizuka N. Karaplis A.C. Henderson J.E. Warhsawsky H. Lipman M.L. Matsuki Y. Ejiri S. Tanaka M. Izumi N. Ozawa H. Goltzman D. Dev. Biol. 1996; 175: 166-176Crossref PubMed Scopus (216) Google Scholar). There was no labeling observed when the corresponding sense probe was used for hybridization (Fig. 5, panel C). As mentioned above, expression of RoBo-1 mRNA was not seen in the immortalized rat chondrocyte cell line (IRC) or in two chondrocyte-containing tissues, trachea (Fig.1 B) and ear (not shown). This specific expression of RoBo-1 in the epiphyseal chondrocytes and not in other cartilagenous tissues suggests that RoBo-1 is involved in forming mineralized tissue and may provide a marker for differentiation stages of chondrocytic cells. Since RoBo-1 is expressed in areas of bone lengthening and remodeling, we were interested in the regulation of the RoBo-1 mRNA in response to a known bone formation stimulus. The strength at each site in the human skeleton is determined primarily by local mechanical forces placed on the bone. Mediators such as estrogen, parathyroid hormone, or calcitonin also can have substantial effects on bone metabolism and bone mineral density. However, mechanical loading provides the critical signal that leads to formation of bone with the appropriate site-specific strength, density, and architecture. We examined in vivo regulation of RoBo-1 mRNA using two well characterized mechanical loading models capable of producing strains that induce bone formation. In the rat tail vertebral compression model, the eighth caudal vertebra is cyclically compressed along its length to induce bone formation (7Chow J.W.M. Jagger C.J. Chambers T.J. Am. J. Physiol. 1993; 265: E340-E347Crossref PubMed Google Scholar). The vertebrae were subjected to a single episode of axial loading at strains normally experienced by bones during use. After this intermittent mechanical loading, we observed a reproducible increase in the RoBo-1 in situ hybridization signal in both the growth plate and primary spongiosa. This signal reached a maximum by 6 h (Fig. 5, panels D (low magnification) and E(higher magnification)) and returned to base line 24 h after loading. No labeling was observed after hybridization with the sense probe (Fig. 5, panel F). In the axial ulna loading model (8Torrance A.G. Mosley J.R. Suswillo R.F.L. Lanyon L.E. Calcif. Tissue. Int. 1994; 54: 241-247Crossref PubMed Scopus (244) Google Scholar), rat ulnae are compressed with intermittent mechanical forces that cause flexing at the weakest point along the bone. To adapt to these forces, new bone is formed at the site of deformation. Six h after this axial mechanical loading, RoBo-1 mRNA expression increased in the diaphysis of loaded ulnae compared with that of the contralateral control ulnae (Fig.6). When densitometric values for RoBo-1 were normalized for β-actin mRNA expression, the level of RoBo-1 mRNA expression was increased more than 2-fold relative to that seen in the control bones (control = 0.30 ± 0.06, loaded = 0.63 ± 0.09, p = 0.035). The data from the two in vivo loading models implies that RoBo-1 may provide an important function in the ability of the bone to adapt to external forces applied to the skeleton. Estrogen is known to have effects on bone mass, and removal of estrogen by ovariectomy results in the rapid loss of bone in rats (23Wronski T.J. Cinstron M. Doherty A.L. Dann L.M. Endocrinology. 1988; 123: 681-686Crossref PubMed Scopus (325) Google Scholar). This loss can be prevented by restoration of estrogen. Since estrogen regulates bone metabolism and has been shown to alter the mRNA levels of known bone matrix proteins (24Salih M.A. Chung-Ching L. Arjmandi B.H. Kalu D.N. Bone Miner. 1993; 23: 285-299Abstract Full Text PDF PubMed Scopus (22) Google Scholar), we examined the effects of estradiol on RoBo-1 mRNA levels in ovariectomized rats. A single oral administration of estradiol (30 μg/kg) in previously ovariectomized rats increased the RoBo-1 mRNA levels in the tibial metaphysis over that of the vehicle controls at 24 and 48 h (Fig.7). Increases in RoBo-1 mRNA levels were seen as early as 2 h after estradiol (data not shown). This regulation by a known systemic mediator of bone density is further evidence that RoBo-1 is involved in the metabolism of bone. We described here the discovery of the novel bone-specific protein, RoBo-1, that is abundantly expressed in rat bone mRNA. Based on its sequence homologies, RoBo-1 is a new member of the uPAR/CD59/Ly-6 snake toxin family. These proteins contain a fundamental structural unit of approximately 90 amino acids that includes 8–10 cysteines that form internal disulfide bridges. Of interest is the fact that all of the mammalian members to date have only one of these structural units, with the exception of uPAR, which contains three. Also, studies have shown that these proteins share a common genomic organization (25Casey J.R. Petranka J.G. Kottra J. Fleenor D.E. Rosse W.F. Blood. 1994; 84: 1151-1156Crossref PubMed Google Scholar). The 90 amino acid structural unit of the single domain proteins is coded for by two exons. This suggests that uPAR arose from a common ancestral gene likely resulting from internal triplication of the two exons. Since RoBo-1 has two cysteine structural domains, it likely has a similar gene organization resulting from internal gene duplication of similar ancestral exons. In fact, preliminary PCR analysis of rat genomic DNA suggests that RoBo-1 has an exon structure like other members of this family. The closest homology of RoBo-1 is with the snake PLA2 inhibitors. These inhibitor proteins appear to have two cysteine domains, similar to RoBo-1. The Naja Naja PLA2 inhibitor functions as a heterotrimer composed of two 30-kDa subunits and a single 25-kDa subunit to inhibit PLA2. The Crotalus neutralizing factor PLA2 inhibitor functions as a oligomeric aggregate of 6–8 subunits to inhibit the actions of the PLA2 on cellular membranes. Although it is not known if RoBo-1 can inhibit PLA2, it is interesting to speculate that RoBo-1 may form functional homodimer, heterodimer, or oligomeric structures. To date, none of the known uPAR/CD59/Ly-6 members have been found localized in a specific tissue. However, RoBo-1 mRNA expression was detected selectively in bone tissue and in growth plate cartilage. It is significant that RoBo-1 is expressed at sites of endochondral and membranous bone formation. Endochondral bone is formed in the growth plate by resorption of the calcified cartilage and replacement with bone. On the other hand, intramembranous bone is formed by osteoblasts without a prior cartilage template. Since RoBo-1 is expressed in osteoblast and growth plate chondrocytes but not in other cartilage tissue such as trachea and ear, it is likely to be involved in the bone formation functions of these two different cell types. Both estrogen and intermittent mechanical stimulation are known to have net positive effects on bone density. Furthermore, it has been demonstrated that estrogen modulates the ability of the skeleton to respond to mechanical forces (26Jagger C.J. Chow J.W.M. Chambers T.J. J. Clin. Invest. 1996; 98: 2351-2357Crossref PubMed Scopus (71) Google Scholar). RoBo-1 mRNA levels increased after estrogen replacement following ovariectomy. Similar increases were seen in bones after mechanical stimulation. It is significant that we observed increases after mechanical stimulation at sites of both endochondral (growth plate) and membranous bone formation (diaphysis). Since RoBo-1 is up-regulated when bone is formed through two different mechanisms, it suggests that RoBo-1 is critical to the ultimate formation of mineralized tissue. Finally, the increased expression of RoBo-1 after mechanical stimulation and its homology to the snake PLA2 inhibitors is of particular interest for a number of reasons. After mechanical stimulation, there is a rapid, local increase in production of prostaglandins, which are potent regulators of bone formation and resorption (27Norrdin R.W. Lee W.S.S. High W.B. Prostaglandins Leukotrienes Essent. Fatty Acids. 1990; 41: 139-150Abstract Full Text PDF PubMed Scopus (172) Google Scholar, 28Rawlinson S.C. El-Haj A.J. Minter S.L. Tavares I.A. Bennett A. Lanyon L.E. J. Bone Miner. Res. 1991; 6: 1345-1351Crossref PubMed Scopus (170) Google Scholar). Since a key regulator of prostaglandin synthesis is PLA2, a highly tissue-restricted inhibitor could provide a mechanism for local control of prostaglandin-mediated bone formation. Another possible mechanism could be to regulate the PLA2 activity associated with the extracellular matrix vesicles produced by chondrocytes and osteoblasts (29Schwartz Z. Boyan B. Endocrinology. 1988; 122: 2191-2198Crossref PubMed Scopus (144) Google Scholar, 30Schwartz Z. Dennis R. Bonewald L. Swain L. Gomez R. Boyan B.D. Bone (NY). 1992; 13: 51-58Crossref PubMed Scopus (59) Google Scholar). These matrix vesicles play an important role in the mineralization process. Although the function of RoBo-1 remains to be elucidated, its protein homologies, abundant mRNA expression, tissue specificity, and response to positive mediators of bone density suggest that it provides a unique function in the growth or remodeling of bone. We thank S. Stinnett and A. Baktha for assistance with automated DNA sequencing, Dr. Walter Horton (Gerontology Research Center, NIA, National Institutes of Health, Baltimore, MD) for kindly supplying us with RNA from IRC cells, Sharon Steuckle for expert assistance with estrogen in vivostudies, and Drs. Henry Metzger (NIAMS, National Institutes of Health, Bethesda, MD) and Donald McDonnell (Department of Pharmacology, Duke University) for critical review of our manuscript.